The Precision Medicine market is expanding via advancements in genomic sequencing, AI-driven analytics, and collaborative global genomics programs. Key trends include companion diagnostics in oncology ...

The American Academy of Allergy, Asthma & Immunology Annual Meeting will be held Feb. 27 to March 2 in Philadelphia with a ...

Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and decision-making in precision medicine.

Tempus AI, Inc. (NASDAQ:TEM) is one of the best Nancy Pelosi Stocks to buy in 2026. On January 27, Tempus AI, Inc. (NASDAQ:TEM) confirmed that its Immune Profile Score Test accurately predicts patient ...

A growing number of companies offer the enticing promise of optimizing one’s health by tapping into powerful technology they say can map out what diseases a person is susceptible to and possibly catch ...

In part one of season two of MobiHealthNews’ Emerging Technologies series, Mark Zhang, acting assistant under secretary for ...

On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...

Researchers are applying insights into the genetic variations and physiology of obesity to apply tailored interventions to ...

Mirador Therapeutics has raised $250M to advance clinical trials. Read about the Series B financing led by T. Rowe Price and ...

Biomedical research and the practice of medicine, separately and together, are reaching an inflection point: the capacity for description and for collecting data, is expanding dramatically, but the ...

The Marcus Autism Center announced it will conduct the largest study of behavior, brain and genomic biomarkers in children ...